Division for Drug Discovery and Development - Scientific Achievement Award Lecture and Notable Abstracts Platform Presentations
Friday April 30, 2021
10:00 am
-
12:00 pm
Eastern Time (ET)
View session on the EB Virtual Platform (EB registration required)
DDD
Chair :
Tom Parry
Ovid Therapeutics
Benita Sjogren
Purdue Univ
This session features notable students and postdoctoral fellows who submited abstracts for EB 2021. The talks range from basic drug discovery to drug development. It will also include a keynote address from 2021 winner of the ASPET Division for Drug Discovery and Development Scientific Achievement Award.
Speakers
Haru Nomura
- University of Queensland
2A: A Novel Angiotensin Converting Enzyme 2 Stimulator
Carly Baehr
- University of Minnesota
Anti-fentanyl Vaccines and Monoclonal Antibodies are Effective in Prevention and Reversal of Fentanyl-induced Overdose in Rats
Jacqueline Silva
- University of Texas Medical Branch
Bromodomain-Containing Protein 4 (BRD4) Inhibitors as Emerging Therapeutics for Opioid Use Disorder
Daniel Felsing
- University of Texas Medical Branch
Structure Activity Relationships of Novel GPR52 Agonists that Suppress Psychostimulant Behavior
Francis Willard
- Eli Lilly and Company
Novel Pharmacology Approaches for Drugging ClassB GPCRs